Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BW.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.312ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.220ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.142ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.523ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.418ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.389ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.363ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.405ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.282ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.228ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.174ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.88 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XASENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used